Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Podocytes | 14 | 2023 | 91 | 2.330 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 11 | 2023 | 44 | 1.890 |
Why?
|
| Kidney Diseases | 6 | 2023 | 123 | 1.430 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 6 | 2023 | 47 | 0.790 |
Why?
|
| Proteinuria | 10 | 2023 | 83 | 0.760 |
Why?
|
| Mice | 14 | 2023 | 1681 | 0.600 |
Why?
|
| Purpura, Schoenlein-Henoch | 1 | 2016 | 1 | 0.530 |
Why?
|
| Kidney | 3 | 2018 | 181 | 0.530 |
Why?
|
| Dermatitis, Atopic | 1 | 2016 | 21 | 0.520 |
Why?
|
| Animals | 17 | 2023 | 4720 | 0.510 |
Why?
|
| Asthma | 4 | 2017 | 143 | 0.430 |
Why?
|
| Mice, Transgenic | 7 | 2023 | 260 | 0.390 |
Why?
|
| Acute Kidney Injury | 2 | 2023 | 52 | 0.370 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2023 | 31 | 0.340 |
Why?
|
| Taiwan | 7 | 2017 | 14 | 0.330 |
Why?
|
| Glomerular Filtration Rate | 3 | 2019 | 61 | 0.320 |
Why?
|
| Sepsis | 2 | 2023 | 154 | 0.300 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 48 | 0.300 |
Why?
|
| Signal Transduction | 4 | 2019 | 498 | 0.290 |
Why?
|
| Incidence | 8 | 2017 | 790 | 0.290 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 286 | 0.260 |
Why?
|
| Humans | 23 | 2023 | 31073 | 0.260 |
Why?
|
| Kidney Glomerulus | 4 | 2016 | 58 | 0.240 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2016 | 101 | 0.240 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 53 | 0.230 |
Why?
|
| Immunotoxins | 1 | 2023 | 2 | 0.230 |
Why?
|
| Integrins | 1 | 2023 | 21 | 0.220 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 782 | 0.220 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2023 | 7 | 0.220 |
Why?
|
| Hyperglycemia | 1 | 2023 | 37 | 0.220 |
Why?
|
| Kidney Transplantation | 2 | 2015 | 126 | 0.210 |
Why?
|
| Risk Assessment | 4 | 2020 | 718 | 0.190 |
Why?
|
| HEK293 Cells | 2 | 2019 | 71 | 0.190 |
Why?
|
| Biopsy | 2 | 2019 | 249 | 0.180 |
Why?
|
| Retrospective Studies | 7 | 2019 | 3665 | 0.180 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2020 | 6 | 0.180 |
Why?
|
| Risk Factors | 6 | 2016 | 2591 | 0.180 |
Why?
|
| Female | 15 | 2020 | 17017 | 0.170 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 46 | 0.170 |
Why?
|
| Coronary Angiography | 1 | 2020 | 99 | 0.170 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2019 | 2 | 0.170 |
Why?
|
| Receptor, PAR-2 | 1 | 2019 | 4 | 0.170 |
Why?
|
| Protein Domains | 1 | 2019 | 11 | 0.170 |
Why?
|
| Adipocytes | 1 | 2019 | 14 | 0.170 |
Why?
|
| Protein Multimerization | 1 | 2019 | 19 | 0.170 |
Why?
|
| Case-Control Studies | 3 | 2016 | 664 | 0.160 |
Why?
|
| Male | 14 | 2020 | 16499 | 0.160 |
Why?
|
| Protein Isoforms | 1 | 2019 | 55 | 0.160 |
Why?
|
| Microscopy, Electron | 1 | 2019 | 75 | 0.160 |
Why?
|
| Annulus Fibrosus | 1 | 2018 | 9 | 0.160 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2018 | 36 | 0.160 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2017 | 2 | 0.150 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 32 | 0.150 |
Why?
|
| Proportional Hazards Models | 5 | 2019 | 370 | 0.150 |
Why?
|
| Adipose Tissue | 1 | 2018 | 78 | 0.150 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 27 | 0.150 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 29 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2018 | 126 | 0.150 |
Why?
|
| Periodontal Diseases | 1 | 2017 | 2 | 0.150 |
Why?
|
| Middle Aged | 12 | 2020 | 10240 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 2 | 2019 | 161 | 0.150 |
Why?
|
| TRPC Cation Channels | 3 | 2023 | 11 | 0.140 |
Why?
|
| Infant | 2 | 2016 | 577 | 0.140 |
Why?
|
| Myeloid Cells | 1 | 2016 | 16 | 0.140 |
Why?
|
| Child, Preschool | 2 | 2016 | 691 | 0.140 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2018 | 130 | 0.140 |
Why?
|
| Intervertebral Disc | 1 | 2018 | 218 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 232 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2017 | 184 | 0.140 |
Why?
|
| Adult | 11 | 2019 | 8950 | 0.140 |
Why?
|
| Sjogren's Syndrome | 1 | 2016 | 6 | 0.130 |
Why?
|
| Integrin beta3 | 1 | 2015 | 7 | 0.130 |
Why?
|
| Plasma Exchange | 1 | 2015 | 16 | 0.130 |
Why?
|
| Cells, Cultured | 6 | 2018 | 686 | 0.130 |
Why?
|
| Hydroxyquinolines | 1 | 2015 | 4 | 0.130 |
Why?
|
| Integrin beta1 | 1 | 2015 | 9 | 0.130 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 95 | 0.120 |
Why?
|
| Biomarkers | 4 | 2023 | 734 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2015 | 60 | 0.120 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2014 | 9 | 0.120 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2015 | 46 | 0.120 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2015 | 66 | 0.120 |
Why?
|
| Mice, Knockout | 4 | 2017 | 322 | 0.120 |
Why?
|
| Child | 2 | 2016 | 1431 | 0.120 |
Why?
|
| Hospitalization | 1 | 2017 | 336 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 463 | 0.120 |
Why?
|
| Postoperative Complications | 2 | 2020 | 997 | 0.110 |
Why?
|
| Cohort Studies | 5 | 2017 | 2046 | 0.110 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 133 | 0.100 |
Why?
|
| Cell Movement | 2 | 2015 | 105 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 25 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 214 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 80 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2014 | 221 | 0.090 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2010 | 6 | 0.090 |
Why?
|
| TRPC6 Cation Channel | 3 | 2023 | 8 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2010 | 71 | 0.090 |
Why?
|
| Aged | 7 | 2020 | 10082 | 0.080 |
Why?
|
| Young Adult | 4 | 2016 | 2061 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 691 | 0.080 |
Why?
|
| Aging | 1 | 2018 | 1729 | 0.080 |
Why?
|
| Membrane Microdomains | 1 | 2007 | 15 | 0.080 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2007 | 23 | 0.080 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 36 | 0.070 |
Why?
|
| Cathepsins | 1 | 2007 | 7 | 0.070 |
Why?
|
| Dynamins | 1 | 2007 | 10 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 1 | 2007 | 9 | 0.070 |
Why?
|
| Cytoskeleton | 3 | 2014 | 52 | 0.070 |
Why?
|
| Propensity Score | 2 | 2017 | 36 | 0.070 |
Why?
|
| Models, Biological | 1 | 2007 | 346 | 0.060 |
Why?
|
| Time Factors | 3 | 2017 | 1680 | 0.060 |
Why?
|
| Rats | 3 | 2015 | 871 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 190 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2005 | 125 | 0.060 |
Why?
|
| Recurrence | 2 | 2015 | 375 | 0.060 |
Why?
|
| Disease Progression | 2 | 2017 | 833 | 0.060 |
Why?
|
| Insulin | 1 | 2023 | 97 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2023 | 172 | 0.050 |
Why?
|
| Actins | 2 | 2015 | 46 | 0.050 |
Why?
|
| Inflammation | 1 | 2023 | 361 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 2020 | 10 | 0.040 |
Why?
|
| Cathepsin L | 2 | 2011 | 9 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 1935 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 293 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 9 | 0.040 |
Why?
|
| Nucleus Pulposus | 1 | 2018 | 12 | 0.040 |
Why?
|
| Growth Plate | 1 | 2018 | 24 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 271 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2011 | 329 | 0.040 |
Why?
|
| Critical Illness | 1 | 2020 | 141 | 0.040 |
Why?
|
| Bone Development | 1 | 2018 | 37 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2018 | 152 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 7 | 0.040 |
Why?
|
| Proteolysis | 1 | 2017 | 13 | 0.040 |
Why?
|
| Protein Folding | 1 | 2017 | 24 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 270 | 0.040 |
Why?
|
| Chondrocytes | 1 | 2018 | 208 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2020 | 328 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2016 | 58 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 59 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 46 | 0.030 |
Why?
|
| Pneumonia | 1 | 2017 | 75 | 0.030 |
Why?
|
| Apoptosis | 1 | 2017 | 260 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 411 | 0.030 |
Why?
|
| Puromycin Aminonucleoside | 1 | 2015 | 7 | 0.030 |
Why?
|
| Focal Adhesions | 1 | 2015 | 9 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 10 | 0.030 |
Why?
|
| Albuminuria | 1 | 2015 | 22 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 36 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 118 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 273 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 96 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 90 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2015 | 91 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 2014 | 18 | 0.030 |
Why?
|
| Mutation | 2 | 2007 | 409 | 0.030 |
Why?
|
| Adolescent | 2 | 2014 | 2403 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 5197 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 150 | 0.030 |
Why?
|
| Plasmapheresis | 1 | 2013 | 14 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 380 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 39 | 0.030 |
Why?
|
| Rituximab | 1 | 2013 | 55 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 510 | 0.030 |
Why?
|
| Comorbidity | 1 | 2015 | 508 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 128 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 354 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 138 | 0.030 |
Why?
|
| Age Factors | 1 | 2015 | 875 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2014 | 637 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2011 | 14 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2011 | 32 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 164 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 175 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 1899 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2010 | 48 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 130 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 305 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 444 | 0.020 |
Why?
|
| Transfection | 1 | 2006 | 127 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 256 | 0.020 |
Why?
|
| Gene Expression | 1 | 2006 | 239 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2005 | 5 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 467 | 0.020 |
Why?
|
| Pedigree | 1 | 2005 | 75 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 3810 | 0.010 |
Why?
|